Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1958 4
1963 2
1965 1
1966 1
1968 2
1970 1
1971 1
1972 6
1973 2
1974 3
1975 6
1976 3
1977 4
1979 10
1980 3
1981 2
1982 2
1983 6
1984 9
1985 9
1986 15
1987 20
1988 12
1989 14
1990 22
1991 18
1992 8
1993 9
1994 15
1995 17
1996 23
1997 22
1998 15
1999 12
2000 15
2001 19
2002 28
2003 22
2004 26
2005 12
2006 28
2007 18
2008 18
2009 22
2010 17
2011 22
2012 29
2013 42
2014 26
2015 15
2016 15
2017 24
2018 31
2019 26
2020 25
2021 11
Text availability
Article attribute
Article type
Publication date

Search Results

743 results
Results by year
Filters applied: . Clear all
Page 1
Guidelines for Diagnosis and Treatment of Familial Hypercholesterolemia 2017.
Harada-Shiba M, Arai H, Ishigaki Y, Ishibashi S, Okamura T, Ogura M, Dobashi K, Nohara A, Bujo H, Miyauchi K, Yamashita S, Yokote K; Working Group by Japan Atherosclerosis Society for Making Guidance of Familial Hypercholesterolemia. Harada-Shiba M, et al. Among authors: ishibashi s. J Atheroscler Thromb. 2018 Aug 1;25(8):751-770. doi: 10.5551/jat.CR003. Epub 2018 Jun 7. J Atheroscler Thromb. 2018. PMID: 29877295 Free PMC article.
Rationale and design of the Pemafibrate to Reduce Cardiovascular Outcomes by Reducing Triglycerides in Patients with Diabetes (PROMINENT) study.
Pradhan AD, Paynter NP, Everett BM, Glynn RJ, Amarenco P, Elam M, Ginsberg H, Hiatt WR, Ishibashi S, Koenig W, Nordestgaard BG, Fruchart JC, Libby P, Ridker PM. Pradhan AD, et al. Among authors: ishibashi s. Am Heart J. 2018 Dec;206:80-93. doi: 10.1016/j.ahj.2018.09.011. Epub 2018 Sep 29. Am Heart J. 2018. PMID: 30342298 Free article. Review.
Japan Atherosclerosis Society (JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases 2017.
Kinoshita M, Yokote K, Arai H, Iida M, Ishigaki Y, Ishibashi S, Umemoto S, Egusa G, Ohmura H, Okamura T, Kihara S, Koba S, Saito I, Shoji T, Daida H, Tsukamoto K, Deguchi J, Dohi S, Dobashi K, Hamaguchi H, Hara M, Hiro T, Biro S, Fujioka Y, Maruyama C, Miyamoto Y, Murakami Y, Yokode M, Yoshida H, Rakugi H, Wakatsuki A, Yamashita S; Committee for Epidemiology and Clinical Management of Atherosclerosis. Kinoshita M, et al. Among authors: ishibashi s. J Atheroscler Thromb. 2018 Sep 1;25(9):846-984. doi: 10.5551/jat.GL2017. Epub 2018 Aug 22. J Atheroscler Thromb. 2018. PMID: 30135334 Free PMC article. No abstract available.
The selective peroxisome proliferator-activated receptor alpha modulator (SPPARMα) paradigm: conceptual framework and therapeutic potential : A consensus statement from the International Atherosclerosis Society (IAS) and the Residual Risk Reduction Initiative (R3i) Foundation.
Fruchart JC, Santos RD, Aguilar-Salinas C, Aikawa M, Al Rasadi K, Amarenco P, Barter PJ, Ceska R, Corsini A, Després JP, Duriez P, Eckel RH, Ezhov MV, Farnier M, Ginsberg HN, Hermans MP, Ishibashi S, Karpe F, Kodama T, Koenig W, Krempf M, Lim S, Lorenzatti AJ, McPherson R, Nuñez-Cortes JM, Nordestgaard BG, Ogawa H, Packard CJ, Plutzky J, Ponte-Negretti CI, Pradhan A, Ray KK, Reiner Ž, Ridker PM, Ruscica M, Sadikot S, Shimano H, Sritara P, Stock JK, Su TC, Susekov AV, Tartar A, Taskinen MR, Tenenbaum A, Tokgözoğlu LS, Tomlinson B, Tybjærg-Hansen A, Valensi P, Vrablík M, Wahli W, Watts GF, Yamashita S, Yokote K, Zambon A, Libby P. Fruchart JC, et al. Among authors: ishibashi s. Cardiovasc Diabetol. 2019 Jun 4;18(1):71. doi: 10.1186/s12933-019-0864-7. Cardiovasc Diabetol. 2019. PMID: 31164165 Free PMC article. Review.
Statements.
Teramoto T, Sasaki J, Ishibashi S, Birou S, Daida H, Dohi S, Egusa G, Hiro T, Hirobe K, Iida M, Kihara S, Kinoshita M, Maruyama C, Ohta T, Okamura T, Yamashita S, Yokode M, Yokote K; Japan Atherosclerosis Society Committee for Epidemiology and Clinical Management of Atherosclerosis. Teramoto T, et al. Among authors: ishibashi s. J Atheroscler Thromb. 2014;21(4):299-303. doi: 10.5551/jat.ed002. Epub 2014 Apr 12. J Atheroscler Thromb. 2014. PMID: 24727684 Free article. No abstract available.
Mondor's Disease.
Ito H, Ishibashi S, Kaburagi T. Ito H, et al. Among authors: ishibashi s. Intern Med. 2019 Jun 15;58(12):1805. doi: 10.2169/internalmedicine.2024-18. Epub 2019 Feb 25. Intern Med. 2019. PMID: 30799346 Free PMC article. No abstract available.
Diagnosis and management of type I and type V hyperlipoproteinemia.
Gotoda T, Shirai K, Ohta T, Kobayashi J, Yokoyama S, Oikawa S, Bujo H, Ishibashi S, Arai H, Yamashita S, Harada-Shiba M, Eto M, Hayashi T, Sone H, Suzuki H, Yamada N; Research Committee for Primary Hyperlipidemia, Research on Measures against Intractable Diseases by the Ministry of Health, Labour and Welfare in Japan. Gotoda T, et al. Among authors: ishibashi s. J Atheroscler Thromb. 2012;19(1):1-12. doi: 10.5551/jat.10702. Epub 2011 Dec 1. J Atheroscler Thromb. 2012. PMID: 22129523 Free article.
Efficacy and Safety of Pemafibrate, a Novel Selective Peroxisome Proliferator-Activated Receptor α Modulator (SPPARMα): Pooled Analysis of Phase 2 and 3 Studies in Dyslipidemic Patients with or without Statin Combination.
Yamashita S, Arai H, Yokote K, Araki E, Matsushita M, Nojima T, Suganami H, Ishibashi S. Yamashita S, et al. Among authors: ishibashi s. Int J Mol Sci. 2019 Nov 6;20(22):5537. doi: 10.3390/ijms20225537. Int J Mol Sci. 2019. PMID: 31698825 Free PMC article. Clinical Trial.
Effects of Pemafibrate, a Novel Selective PPARα Modulator, on Lipid and Glucose Metabolism in Patients With Type 2 Diabetes and Hypertriglyceridemia: A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trial.
Araki E, Yamashita S, Arai H, Yokote K, Satoh J, Inoguchi T, Nakamura J, Maegawa H, Yoshioka N, Tanizawa Y, Watada H, Suganami H, Ishibashi S. Araki E, et al. Among authors: ishibashi s. Diabetes Care. 2018 Mar;41(3):538-546. doi: 10.2337/dc17-1589. Epub 2018 Jan 3. Diabetes Care. 2018. PMID: 29298800 Clinical Trial.
Efficacy and Safety of Pemafibrate Versus Fenofibrate in Patients with High Triglyceride and Low HDL Cholesterol Levels: A Multicenter, Placebo-Controlled, Double-Blind, Randomized Trial.
Arai H, Yamashita S, Yokote K, Araki E, Suganami H, Ishibashi S; K-877 Study Group. Arai H, et al. Among authors: ishibashi s. J Atheroscler Thromb. 2018 Jun 1;25(6):521-538. doi: 10.5551/jat.44412. Epub 2018 Apr 7. J Atheroscler Thromb. 2018. PMID: 29628483 Free PMC article. Clinical Trial.
743 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page